The U.S. Supreme Court is currently evaluating a legal dispute involving the New Jersey Transit Corporation (NJ Transit), with far-reaching implications for sovereign immunity and the ability of state-run entities to face litigation outside their home states. At issue is whether NJ Transit, created by the New Jersey Legislature over four decades ago, can be sued in the state courts of New York and Pennsylvania, where it operates a substantial portion of its transit services.
The cases arise from separate incidents where plaintiffs Jeffrey Colt and Cedric Galette were injured in accidents involving NJ Transit vehicles. Colt’s lawsuit, filed in New York, has progressed after the New York Court of Appeals ruled that NJ Transit is not an “arm” of the state, thereby allowing the case to move forward. Conversely, Galette’s lawsuit in Pennsylvania was dismissed by the Pennsylvania Supreme Court, which deemed NJ Transit an “arm” of the state, affording it immunity under interstate sovereign immunity.
In a recent oral argument, New Jersey Deputy Solicitor General Michael Zuckerman advanced the state’s position that NJ Transit should be considered akin to a state agency, suggesting that it possesses state-like powers, such as rulemaking and enforcing state laws. Zuckerman emphasized that the New Jersey governor has significant control over NJ Transit’s board and financial operations, calling into question its classification as a public corporation separate from state governance. He asserted that litigation against NJ Transit should be limited to New Jersey, where the state has expressly consented.
Contrasting Zuckerman’s argument, counsel for the plaintiffs, Michael Kimberly, pointed to the distinct legal separation ascribed to public corporations. He stressed that states forming such entities naturally forgo sovereign immunity, a principle purportedly established over a 200-year precedent. This view was echoed by Justice Ketanji Brown Jackson and Justice Amy Coney Barrett, who both showed skepticism that a multifactor approach to sovereign immunity claims altered this standing.
Amid intense questioning, the justices examined factors such as New Jersey’s policy on assuming NJ Transit’s financial liabilities, with Chief Justice John Roberts pointing to the state’s recurrent coverage of NJ Transit’s financial deficits as a potential indicator of state affiliation. However, the debate circled back to formal legal responsibility and the understanding of sovereign immunity in relation to corporation status.
Justice Elena Kagan offered a unique perspective, referencing the 2023 decision in Biden v. Nebraska, drawing a comparison to the Missouri Higher Education Loan Authority’s characterization as a state entity, reportedly similar to NJ Transit’s current standing. The court’s decision is eagerly anticipated by legal practitioners and state-run entities alike, as a ruling could set a precedent in how public corporations are litigated in interstate contexts.
For more on this ongoing legal debate, visit the full coverage at SCOTUSblog.